99% Savings - Buy Just @1 Rs X
Brilinta, a prescription drug, is manufactured in various forms such as Tablet. It is primarily used for the treatment of Heart Attack. Secondary and off-label uses of Brilinta have also been mentioned below.
The optimal dosage of Brilinta is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
Apart from the aforementioned side effects, Brilinta can also lead to other problems, which have been listed below. These side effects of Brilinta are usually temporary and subside with the completion of treatment. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Brilinta has a Moderate effect for pregnant women and Unknown effect on lactating mothers. It is important to know if Brilinta has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Brilinta related warnings section.
Brilinta is contraindicated in people with pre-existing medical conditions like Liver Disease, Bradycardia (Slow Heart Rate), Peptic Ulcer as it can result in adverse effects. Other contraindications of Brilinta have been discussed in the sections ahead.
Besides this, Brilinta may also have severe interaction with some medicines. See below for a complete list.
In addition to the above precautions for Brilinta, it is important to know that it is safe while driving, and is habit-forming.
Brilinta is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Brilinta safe for pregnant women?
Brilinta can have harmful effects in pregnant women. If you experience any discomfort after using Brilinta, then discontinue the use and take your doctor's advice.
Is the use of Brilinta safe during breastfeeding?
In the absence of any scientific study about the side effects of Brilinta in breastfeeding women, information on safety of Brilinta is unavailable.
What is the effect of Brilinta on the Kidneys?
Using Brilinta does not have any harmful effects on kidneys.
What is the effect of Brilinta on the Liver?
Brilinta may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Brilinta on the Heart?
Very few cases of side effects of Brilinta on the heart have been reported.
Brilinta should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Brilinta unless your doctor advises you to do so -
Is this Brilinta habit forming or addictive?
Forming a habit of Brilinta has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Yes, it is safe to do these activities or work after taking Brilinta as it does not make you drowsy.
Is it safe?
Brilinta should be used only after doctor's advice.
Is it able to treat mental disorders?
No, the use of Brilinta in mental disorders is not effective.
Interaction between Food and Brilinta
Due to the absence of research, it is difficult to say how Brilinta and food will interact.
Interaction between Alcohol and Brilinta
It is difficult to say anything about the effect of Brilinta and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Brilinta® (ticagrelor)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1204-1205